-+ 0.00%
-+ 0.00%
-+ 0.00%

PSYENCE BIOMED ANNOUNCES APPROVAL FOR USE OF PSYLABS’ PSILOCYBIN PRODUCT IN PHASE IIB CLINICAL TRIAL

Reuters·12/19/2025 12:00:00

Please log in to view news